Pulmonologyadvisor.com — Website Analysis

pulmonologyadvisor.com has a global rank of #490,068 with an estimated 16 daily visitors. Based on current traffic levels, the domain is valued at approximately $14,284.

The site runs on a .com (commercial) domain with servers located in United States, primary IP address 172.64.33.126, an active HTTPS configuration. Its homepage is titled “Asthma, COPD, Lung Cancer News | Treatment & Research Articles”.

pulmonologyadvisor.com was first registered on 2014-02-06 through CSC CORPORATE DOMAINS, INC..

Based on our analysis, pulmonologyadvisor.com implements HTTPS encryption and scores 0% on security headers. There is room for improvement in security configuration.

pulmonologyadvisor.com is missing 5 of 5 recommended security headers (Strict-Transport-Security, Content-Security-Policy, X-Content-Type-Options, X-Frame-Options, X-XSS-Protection). This leaves visitors more exposed to browser-based attacks.

All values are estimates based on publicly available traffic data.

pulmonologyadvisor.com ranks #490,068 globally. While outside the top 100k, the site maintains an active presence with regular visitors.

With its current visitor volume, pulmonologyadvisor.com has moderate revenue potential. Niche sites at this level often outperform estimates through targeted advertising or affiliate partnerships.

These are the websites closest to pulmonologyadvisor.com in global traffic ranking.

Hosted in the United States, pulmonologyadvisor.com benefits from low latency for North American visitors and proximity to major internet exchange points.

Active since 2014 (12 years), pulmonologyadvisor.com has a decade-plus track record — a sign of a stable, established web presence.

CF-Cache-Status
CF-Ray
Connection
Content-Encoding
Content-Type
Date
Link
Server
Vary
X-Cache
X-Cache-Group
X-Cacheable
X-Distributor
X-Frame-Options
X-WPENGINE-SEGMENT
x-powered-by

Active since 2014 (12 years), pulmonologyadvisor.com has a decade-plus track record — a sign of a stable, established web presence.